Form 8.3 - [Abbvie Inc]
April 02 2020 - 1:09PM
Dow Jones News
TIDM0QCV TIDM0Y7T
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in AbbVie Inc.
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.01 common stock
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 01(st) April 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 68,312,134 4.62608%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 68,312,134 4.62608%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 1,400 73.42
-------------- ----------------------------- -----------------------
Purchase 500 73.02
-------------- ----------------------------- -----------------------
Purchase 718 73.42
-------------- ----------------------------- -----------------------
Purchase 5,387 73.42
-------------- ----------------------------- -----------------------
Purchase 400 73.42
-------------- ----------------------------- -----------------------
Purchase 7,000 73.42
-------------- ----------------------------- -----------------------
Purchase 1,200 73.42
-------------- ----------------------------- -----------------------
Purchase 10,800 73.42
-------------- ----------------------------- -----------------------
Purchase 51,668 73.42
-------------- ----------------------------- -----------------------
Purchase 400 73.42
-------------- ----------------------------- -----------------------
Purchase 1,200 73.42
-------------- ----------------------------- -----------------------
Purchase 200 72.63
-------------- ----------------------------- -----------------------
Purchase 1,100 72.61
-------------- ----------------------------- -----------------------
Purchase 62 73.42
-------------- ----------------------------- -----------------------
Purchase 144 73.42
-------------- ----------------------------- -----------------------
Purchase 2,086 73.42
-------------- ----------------------------- -----------------------
Purchase 225,806 73.42
-------------- ----------------------------- -----------------------
Purchase 93,436 73.42
-------------- ----------------------------- -----------------------
Purchase 2,668 73.42
-------------- ----------------------------- -----------------------
Purchase 3,360 73.42
-------------- ----------------------------- -----------------------
Purchase 900 72.99
-------------- ----------------------------- -----------------------
Purchase 1,800 73.42
-------------- ----------------------------- -----------------------
Purchase 600 73.42
-------------- ----------------------------- -----------------------
Purchase 800 73.42
-------------- ----------------------------- -----------------------
Purchase 33,800 73.42
-------------- ----------------------------- -----------------------
Purchase 800 73.42
-------------- ----------------------------- -----------------------
Purchase 31,400 76.19
-------------- ----------------------------- -----------------------
Purchase 589 73.42
-------------- ----------------------------- -----------------------
Purchase 1,600 73.42
-------------- ----------------------------- -----------------------
Purchase 414 73.42
-------------- ----------------------------- -----------------------
Purchase 3,880 73.42
-------------- ----------------------------- -----------------------
Purchase 9,650 73.42
-------------- ----------------------------- -----------------------
Purchase 154 76.19
-------------- ----------------------------- -----------------------
Sale 600 73.42
-------------- ----------------------------- -----------------------
Sale 31,400 76.19
-------------- ----------------------------- -----------------------
Sale 400 73.42
-------------- ----------------------------- -----------------------
Sale 1,200 73.42
-------------- ----------------------------- -----------------------
Sale 400 73.42
-------------- ----------------------------- -----------------------
Sale 800 73.42
-------------- ----------------------------- -----------------------
Sale 100 73.42
-------------- ----------------------------- -----------------------
Sale 491,617 73.42
-------------- ----------------------------- -----------------------
Sale 700 73.42
-------------- ----------------------------- -----------------------
Sale 17,898 73.42
-------------- ----------------------------- -----------------------
Sale 520 73.42
-------------- ----------------------------- -----------------------
Sale 11,277 73.42
-------------- ----------------------------- -----------------------
Sale 5,700 73.42
-------------- ----------------------------- -----------------------
Sale 800 73.42
-------------- ----------------------------- -----------------------
Sale 1,200 73.42
-------------- ----------------------------- -----------------------
Sale 1,412 73.42
-------------- ----------------------------- -----------------------
Sale 4,850 73.42
-------------- ----------------------------- -----------------------
Sale 9,650 73.42
-------------- ----------------------------- -----------------------
Sale 128 73.42
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -----------------
Date of disclosure 02(nd) April 2020
------------------------------------------------------- -----------------
Contact name Lionel Colaco
------------------------------------------------------- -----------------
Telephone number 020 33956098
------------------------------------------------------- -----------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -----------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -----------------
(END) Dow Jones Newswires
April 02, 2020 12:54 ET (16:54 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Allergan (NYSE:AGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From Apr 2023 to Apr 2024
